Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Usana Health Sciences (USNA) Consolidated Net Income (2016 - 2026)

Usana Health Sciences has reported Consolidated Net Income over the past 17 years, most recently at $7.0 million for Q2 2026.

  • Quarterly Consolidated Net Income fell 25.09% to $7.0 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $9.1 million through Apr 2026, down 73.73% year-over-year, with the annual reading at $11.5 million for FY2026, 72.71% down from the prior year.
  • Consolidated Net Income was $7.0 million for Q2 2026 at Usana Health Sciences, up from -$1.6 million in the prior quarter.
  • Over five years, Consolidated Net Income peaked at $31.5 million in Q1 2022 and troughed at -$6.7 million in Q3 2025.
  • The 5-year median for Consolidated Net Income is $12.1 million (2022), against an average of $12.5 million.
  • Year-over-year, Consolidated Net Income skyrocketed 31.04% in 2023 and then plummeted 162.81% in 2025.
  • A 5-year view of Consolidated Net Income shows it stood at $12.8 million in 2022, then surged by 31.04% to $16.8 million in 2023, then crashed by 73.26% to $4.5 million in 2024, then plummeted by 248.57% to -$6.7 million in 2025, then soared by 204.46% to $7.0 million in 2026.
  • Per Business Quant, the three most recent readings for USNA's Consolidated Net Income are $7.0 million (Q2 2026), -$1.6 million (Q1 2026), and -$6.7 million (Q3 2025).